| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/10/2003 | CN1441675A Compositions and methods for achieving immune suppression |
| 09/10/2003 | CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors |
| 09/10/2003 | CN1441672A Methods for treatment of inflammatory diseases |
| 09/10/2003 | CN1441661A Cosmetic compositions for reducing fat and method of using same |
| 09/10/2003 | CN1440809A New use of neutral proteinase in treating burns |
| 09/10/2003 | CN1440798A Tinea treating medicine |
| 09/10/2003 | CN1440796A Medicine for clearing away heat and toxic matter, promoting diuresis and stopping itching |
| 09/10/2003 | CN1440793A Acne-eliminating moutain flower tea |
| 09/10/2003 | CN1440783A Externally applied medicine for treating burns and sore ulcer |
| 09/10/2003 | CN1440777A Acne treating medicine |
| 09/10/2003 | CN1440775A Ointment for treating burns and scalds |
| 09/10/2003 | CN1440774A Ointment for treating burns and scalds, sore, bone tuberculosis and wounds |
| 09/10/2003 | CN1440767A Recipe of decoction for treating skin diseases |
| 09/10/2003 | CN1440765A Medicine for treating burns and scalds |
| 09/10/2003 | CN1440761A Keloid-treating medicine powder with functions of promoting blood circulation, dispersing blood clots and expelling toxin |
| 09/10/2003 | CN1440758A Bioactive hill wasp powder and its prepn |
| 09/10/2003 | CN1120745C Microcapsule containingt core material and its producing method |
| 09/10/2003 | CN1120722C External used paste for treating leukoderma, leukoplakia valvae and other vitiligines, and its preparing method |
| 09/10/2003 | CN1120705C Skin nursing cream for curing comedo |
| 09/09/2003 | US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 09/09/2003 | US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury |
| 09/09/2003 | US6617352 Compounds and methods for the inhibition of the expression of VCAM-1 |
| 09/09/2003 | US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | US6616933 Excitatory amino acid inhibitors for treating sensitive skins |
| 09/09/2003 | US6616919 1,1,1-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2078814C Substituted pyridinylamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments |
| 09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
| 09/04/2003 | WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 09/04/2003 | WO2003072714A2 Follistatin domain containing proteins |
| 09/04/2003 | WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/04/2003 | WO2003072580A1 1-[ALKYL], 1-[HETEROARYL)ALKYL] AND 1-[ARYL)ALKYL]-7-(PYRIMIDIN-4-YL)-IMADAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES |
| 09/04/2003 | WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/04/2003 | WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 09/04/2003 | WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 09/04/2003 | WO2003072556A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient |
| 09/04/2003 | WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/04/2003 | WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | WO2003072126A2 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 09/04/2003 | WO2003072120A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis |
| 09/04/2003 | WO2003072119A1 External compositions for the skin |
| 09/04/2003 | WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | WO2003072079A1 Soy composition for balancing combination skin |
| 09/04/2003 | WO2003072072A1 Method of stimulation of melanin production and induction of skin tanning |
| 09/04/2003 | WO2003072071A1 Topical dapsone for the treatment of acne |
| 09/04/2003 | WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/04/2003 | WO2003072060A2 Polypeptide formulation |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | WO2003072026A2 Method of reducing and treating uvb-induced immunosuppression |
| 09/04/2003 | WO2003072013A2 Novel applications of statins in dermatology and corresponding pharmaceutical formulations |
| 09/04/2003 | WO2003064472A3 Treatment of ms with goat serum |
| 09/04/2003 | WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 09/04/2003 | WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents |
| 09/04/2003 | WO2003039442A3 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
| 09/04/2003 | WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 09/04/2003 | WO2003018743A3 Emu-based formulations for wound treatment |
| 09/04/2003 | WO2003013461A8 Cosmetic composition and method of treating skin |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS |
| 09/04/2003 | WO2002046389A3 Genes associated with allergic hypersensitivity and mast cell activation |
| 09/04/2003 | WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors |
| 09/04/2003 | WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 09/04/2003 | WO2001085193A3 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | US20030167525 Desaturase genes and uses thereof |
| 09/04/2003 | US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166881 Variations, modulation in gene expression; transgenic animals; skin disorders |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 09/04/2003 | US20030166731 Method of treating hair loss using diphenylether derivatives |
| 09/04/2003 | US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives |
| 09/04/2003 | US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |
| 09/04/2003 | US20030166655 Acyclic nucleotide phosphodiesterase of type 4 inhibitors; antiinflammatory agents; antiallergens; antiarthritis agents, rheumatic diseases; AIDS; gastrointestinal, respiratory, brain, urogenital disorders |
| 09/04/2003 | US20030166652 Chemical compounds |
| 09/04/2003 | US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166633 Pyridinylimidazoles |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166582 Aryl fused azapolycyclic compounds |
| 09/04/2003 | US20030166572 2-Amino-3-hydroxy-4-tert-leucyl-amino-5 phenyl-pentanoic acid amide derivatives |
| 09/04/2003 | US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/04/2003 | US20030166568 Organic compounds |
| 09/04/2003 | US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166535 Preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Intestinal trefoil peptides are administered in effective concentrations either alone or in combination with different therapeutic agents. |